Klaus-Peter Schmitz

Klaus-Peter Schmitz

Auto-generated profile, based on publicly available information

Klaus-Peter Schmitz

Institute for ImplantTechnology and Biomaterials e.V. and Institute for Biomedical Engineering, Rostock University Medical Center, Rostock-Warnemuende , Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
WSWolfram Schmidt
Wolfram Schmidt
PBPeter Behrens
Peter Behrens
CBChristoph Brandt-Wunderlich
Christoph Brandt-Wunderlich
SSStefan Siewert
Stefan Siewert
NGNiels Grabow
Niels Grabow
KSKlaus-Peter Schmitz
Klaus-Peter Schmitz

28 February 2014
Verified
Book Chapter
Closed access
PDF file
Christopher C. BerndtChristopher C. Berndt
Christopher C. Berndt
FHFahad Hasan
Fahad Hasan
UTU. Tietz
U. Tietz
KSK.-P. Schmitz
K.-P. Schmitz

1 September 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
KVKarsten Voss
Karsten Voss
KFKaren Falke
Karen Falke
ABArne Bernsdorf
Arne Bernsdorf
NGNiels Grabow
Niels Grabow
CKChristian Kastner
Christian Kastner
MHMarina Hovakimyan
Marina Hovakimyan

9 February 2012 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
HMHeiner Martin
Heiner Martin
UBUlf Bahlke
Ulf Bahlke
ADAlbrecht Dietze
Albrecht Dietze
Volker ZschorlichVolker Zschorlich
Volker Zschorlich
KSKlaus-Peter Schmitz
Klaus-Peter Schmitz
TMThomas Mittlmeier
Thomas Mittlmeier
It is often suggested that sagittal instability at the first tarso-metatarsal joint level is a primary factor for hallux valgus and that sagittal instability increases with the progression of the deformity. The assessment of the degree of vertical instability is usually made by clinical evaluation while any measurements mostly refer to a static assessment of medial ray mobility (i.e. the plantar/dorsal flexion in the sagittal plane). Testing methods currently available cannot attribute the degree of mobility to the corresponding anatomical joints making up the medial column of the foot. The aim of this study was to develop a technique which allows for a quantification of the in-vivo sagittal mobility of the joints of the medial foot column during the roll-over process under full weight bearing.

8 January 2018 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
WSWolfram Schmidt
Wolfram Schmidt
PLPeter A. Lanzer
Peter A. Lanzer
PBPeter Behrens
Peter Behrens
CBChristoph Brandt-Wunderlich
Christoph Brandt-Wunderlich
AÖAlper Öner
Alper Öner
NGNiels Grabow
Niels Grabow
Drug-eluting stents (DES) compared to bare metal stents (BMS) have shown superior clinical performance, but are considered less suitable in complex cases. Most studies do not distinguish between DES and BMS with respect to their mechanical performance. The objective was to obtain mechanical parameters for direct comparison of BMS and DES. In vitro bench tests evaluated crimped stent profiles, crossability in stenosis models, elastic recoil, bending stiffness (crimped and expanded), and scaffolding properties. The study included five pairs of BMS and DES each with the same stent platforms (all n = 5; PRO-Kinetic Energy, Orsiro: BIOTRONIK AG, Bülach, Switzerland; MULTI-LINK 8, XIENCE Xpedition: Abbott Vascular, Temecula, CA; REBEL Monorail, Promus PREMIER, Boston Scientific, Marlborough, MA; Integrity, Resolute Integrity, Medtronic, Minneapolis, MN; Kaname, Ultimaster: Terumo Corporation, Tokyo, Japan). Statistical analysis used pooled variance t tests for pairwise comparison of BMS with DES. Crimped profiles in BMS groups ranged from 0.97 ± 0.01 mm (PRO-Kinetic Energy) to 1.13 ± 0.01 mm (Kaname) and in DES groups from 1.02 ± 0.01 mm (Orsiro) to 1.13 ± 0.01 mm (Ultimaster). Crossability was best for low profile stent systems. Elastic recoil ranged from 4.07 ± 0.22% (Orsiro) to 5.87 ± 0.54% (REBEL Monorail) including both BMS and DES. The bending stiffness of crimped and expanded stents showed no systematic differences between BMS and DES neither did the scaffolding. Based on in vitro measurements BMS appear superior to DES in some aspects of mechanical performance, yet the differences are small and not class uniform. The data provide assistance in selecting the optimal system for treatment and assessment of new generations of bioresorbable scaffolds. Trial registration: not applicable

1 January 2013
Verified
Journal Article
Closed access
WSWolfram Schmidt
Wolfram Schmidt
CKChristian Kastner
Christian Kastner
KSKatrin Sternberg
Katrin Sternberg
RAReto Allemann
Reto Allemann
MLMarian Löbler
Marian Löbler
KSKlaus-Peter Schmitz
Klaus-Peter Schmitz